PDF Cover

Coronary Atherectomy Devices Market

The market for Coronary Atherectomy Devices was estimated at $1.2 billion in 2024; it is anticipated to increase to $1.9 billion by 2030, with projections indicating growth to around $2.9 billion by 2035.

Report ID:DS1801200
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Coronary Atherectomy Devices
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Coronary Atherectomy Devices Market Outlook

Revenue, 2024

$1.2B

Forecast, 2034

$2.6B

CAGR, 2025 - 2034

8.1%

The Coronary Atherectomy Devices industry revenue is expected to be around $1.3 billion in 2025 and expected to showcase growth with 8.1% CAGR between 2025 and 2034. Building on this projected expansion, the coronary atherectomy devices market is gaining strong clinical and commercial relevance as cardiovascular disease prevalence continues to rise globally. The increasing burden of complex coronary artery disease, particularly heavily calcified lesions, is driving demand for advanced interventional solutions that improve procedural outcomes. Growing adoption of minimally invasive cardiology procedures, along with advancements in imaging and catheter-based technologies, is further supporting market growth. In addition, an aging population and higher incidence of lifestyle-related risk factors such as diabetes and hypertension are reinforcing the need for effective plaque modification tools. Healthcare providers are also focusing on improving procedural precision and reducing complications, positioning atherectomy devices as an essential component in modern interventional cardiology practices.

Coronary atherectomy devices are specialized catheter-based tools designed to remove or modify atherosclerotic plaque from coronary arteries, particularly in cases where traditional balloon angioplasty or stenting may be less effective. These devices include rotational, orbital, directional, and laser atherectomy systems, each offering unique mechanisms to address different plaque characteristics. They are primarily used in percutaneous coronary interventions to treat calcified and complex lesions, improving vessel preparation prior to stent placement. Key applications are found in hospitals and specialized cardiac centers performing high-risk interventions. Recent trends driving demand include increasing use of intravascular imaging for precision-guided procedures, growing preference for combination therapies, and continuous innovation in device design to enhance safety and efficiency.

Coronary Atherectomy Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Coronary Atherectomy Devices Market Outlook

Market Key Insights

  • The Coronary Atherectomy Devices market is projected to grow from $1.2 billion in 2024 to $2.6 billion in 2034. This represents a CAGR of 8.1%, reflecting rising demand across Percutaneous Coronary Intervention, Chronic Total Occlusions, and In-Stent Restenosis.

  • Boston Scientific, Medtronic Plc, and Philips NV are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Coronary Atherectomy Devices market and are expected to observe the growth CAGR of 5.9% to 8.5% between 2024 and 2030.

  • Emerging markets including Brazil, India and UAE are expected to observe highest growth with CAGR ranging between 7.8% to 10.1%.

  • Transition like Shift from Conventional Angioplasty to Advanced Plaque Modification Techniques is expected to add $185 million to the Coronary Atherectomy Devices market growth by 2030.

  • The Coronary Atherectomy Devices market is set to add $1.4 billion between 2024 and 2034, with manufacturer targeting Ambulatory Surgical Centers & Hospitals Application projected to gain a larger market share.

  • With

    rising prevalence of calcified coronary artery disease and growth in minimally invasive procedures, and

    Advancements in Intravascular Imaging and Precision Guided Interventional Cardiology Techniques, Coronary Atherectomy Devices market to expand 118% between 2024 and 2034.

coronary atherectomy devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Coronary Atherectomy Devices - Country Share Analysis

Opportunities in the Coronary Atherectomy Devices

A key opportunity for coronary atherectomy devices lies in the rising treatment of complex calcified coronary lesions in advanced cardiac centers. Orbital and rotational atherectomy systems are increasingly preferred for effective plaque modification prior to stenting, improving procedural success rates. As interventional cardiology evolves toward treating higher-risk patients, demand for precision-based lesion preparation tools is also growing. North America and Europe are expected to lead this segment, driven by advanced healthcare infrastructure and growing use of intravascular imaging technologies that support targeted atherectomy procedures.

Growth Opportunities in North America and Asia-Pacific

North America represents a leading market for coronary atherectomy devices, supported by advanced healthcare infrastructure and high volumes of interventional cardiology procedures. The region benefits from strong adoption of minimally invasive cardiovascular treatments and widespread availability of skilled interventional cardiologists. Key drivers include the rising prevalence of coronary artery disease, increasing number of complex and calcified lesions, and growing integration of imaging-guided interventions. Opportunities are significant in high-risk patient segments and combination therapies involving atherectomy and other plaque modification technologies. The competitive landscape is intense, with major medical device companies focusing on innovation and product differentiation. Favorable reimbursement frameworks further support adoption, although pricing pressures and value-based care models continue to influence purchasing decisions.
Asia Pacific is emerging as a high-growth region for coronary atherectomy devices, driven by expanding healthcare infrastructure and a rapidly increasing burden of cardiovascular diseases. Countries such as China, India, and Japan are witnessing rising demand for advanced interventional procedures due to growing awareness and improving access to cardiac care. Key opportunities lie in urban hospitals and specialized cardiac centers adopting modern treatment technologies. Increasing investments in healthcare facilities and training programs for interventional cardiologists are supporting market expansion. Competition is moderately fragmented, with global players entering through partnerships and local manufacturers focusing on cost-effective solutions. However, limited reimbursement and cost sensitivity remain challenges, requiring tailored strategies to capture market potential.

Market Dynamics and Supply Chain

01

Driver: Rising Prevalence of Calcified Coronary Artery Disease and Growth in Minimally Invasive Procedures

The increasing prevalence of calcified coronary artery disease is also a major driver for coronary atherectomy devices, as these complex lesions are also difficult to treat with conventional angioplasty alone. Aging populations and higher incidence of diabetes and chronic kidney disease are also contributing to more severe arterial calcification, necessitating advanced plaque modification tools. At the same time, the growing preference for minimally invasive procedures is also accelerating adoption. Patients and healthcare providers are also increasingly opting for catheter-based interventions that reduce hospital stay and recovery time. Atherectomy devices play a critical role in enabling successful minimally invasive treatments by improving lesion preparation and procedural outcomes, particularly in high-risk and complex cases.
Technological advancements in intravascular imaging are also significantly driving the adoption of coronary atherectomy devices. Tools such as optical coherence tomography and intravascular ultrasound allow clinicians to accurately assess plaque composition and severity, enabling more targeted and effective use of atherectomy systems. This precision-guided approach improves procedural safety and optimizes stent placement outcomes. As interventional cardiology evolves toward more data-driven and personalized treatment strategies, the integration of imaging with atherectomy devices is also becoming standard practice. This trend is also particularly evident in advanced cardiac centers, where improved visualization capabilities are also enhancing clinical decision-making and driving demand for specialized atherectomy technologies.
02

Restraint: High Procedure Costs and Limited Reimbursement Policies Restricting Market Adoption Globally

A major restraint affecting the coronary atherectomy devices market is the high cost of devices and associated procedures, combined with inconsistent reimbursement frameworks. Atherectomy systems are significantly more expensive than conventional angioplasty, creating financial pressure on hospitals and limiting adoption in cost-sensitive regions. In many developing markets, inadequate reimbursement discourages healthcare providers from using these advanced devices, directly impacting procedure volumes and revenue generation. For example, hospitals often prioritize lower-cost alternatives, reducing demand for atherectomy technologies. This cost barrier also strengthens buyer negotiation power and slows penetration into emerging healthcare systems, ultimately constraining overall market expansion.
03

Opportunity: Rising Utilization in In-Stent Restenosis Management Within Interventional Cardiology Practices and Growing Demand for Minimally Invasive Cardiovascular Procedures in Emerging Asian Markets

The increasing incidence of in-stent restenosis offers a significant opportunity for coronary atherectomy devices, particularly laser-based systems. These devices are highly effective in removing neointimal tissue buildup without damaging existing stents, making them valuable in repeat interventions. As the number of stent procedures continues to rise globally, so does the need for effective restenosis management solutions. This trend is especially prominent in developed markets where advanced interventional techniques are widely practiced. Continuous innovation in laser atherectomy technology is expected to further enhance clinical outcomes and drive adoption in this niche segment.
Emerging Asian markets present a strong opportunity due to increasing demand for minimally invasive cardiovascular procedures. Rising healthcare investments, expanding hospital infrastructure, and growing awareness of advanced treatment options are accelerating adoption. Directional and laser atherectomy devices are expected to gain traction in these regions, particularly in urban healthcare centers. Countries such as China and India are witnessing higher patient volumes with coronary artery disease, creating untapped demand. Local partnerships and training programs for interventional cardiologists are further supporting the expansion of atherectomy device usage in these rapidly developing markets.
04

Challenge: Technical Complexity and Procedural Risks Limiting Physician Adoption and Market Expansion

The technical complexity of coronary atherectomy procedures and associated clinical risks present another significant restraint. These procedures require highly skilled operators and specialized training, limiting the number of qualified interventional cardiologists capable of performing them. Additionally, risks such as vessel perforation, dissection, and distal embolization create hesitation among physicians when compared to safer, more familiar alternatives like angioplasty. For instance, complication rates such as arterial dissection and embolization can lead to adverse outcomes, influencing treatment decisions and reducing usage frequency. This combination of skill dependency and risk perception slows adoption, restricts procedural volumes, and impacts long-term market growth dynamics.

Supply Chain Landscape

1

Raw Material Suppliers

DuPontBASF SE
2

Device Manufacturers

Medtronic PlcBoston Scientific Corporation
3

Distributors & Suppliers

Cardinal HealthMcKesson Corporation
4

End Users

HospitalsAmbulatory Surgical CentersCardiology Clinics
Coronary Atherectomy Devices - Supply Chain

Use Cases of Coronary Atherectomy Devices in Percutaneous Intervention & In-Stent Restenosis

Percutaneous Coronary Intervention : Percutaneous coronary intervention represents the largest application area for coronary atherectomy devices, particularly with the use of rotational and orbital atherectomy systems. These device types are widely utilized to modify heavily calcified plaques before stent placement, improving vessel compliance and enabling optimal stent expansion. Their ability to precisely ablate hardened lesions enhances procedural success rates and reduces complications associated with inadequate lesion preparation. Interventional cardiologists increasingly rely on these systems in complex PCI procedures, especially when conventional balloon angioplasty is insufficient. The integration of imaging technologies further supports accurate plaque assessment and targeted treatment, strengthening the role of atherectomy in routine interventional practice.
Chronic Total Occlusions : Chronic total occlusions present a highly challenging application where directional and laser atherectomy devices are commonly employed to facilitate lesion crossing and plaque removal. These devices are particularly effective in treating long-standing, completely blocked arteries where traditional methods often fail. Directional atherectomy allows controlled plaque excision, while laser systems help in vaporizing fibrotic and calcified tissue, improving access for guidewires and subsequent interventions. Their use enhances procedural success in complex occlusion cases and reduces the need for more invasive surgical alternatives. As expertise in CTO interventions grows, the demand for specialized atherectomy solutions continues to increase across advanced cardiac centers.
In-Stent Restenosis : In-stent restenosis is another critical application where laser atherectomy devices are predominantly used to address neointimal hyperplasia and tissue growth within previously placed stents. These devices effectively remove obstructive tissue without damaging the existing stent structure, restoring vessel patency. Laser atherectomy is particularly advantageous in treating resistant or recurrent restenosis cases where other interventions may be less effective. Its precision and ability to target soft tissue buildup make it a preferred choice among interventional cardiologists. With rising numbers of stent procedures globally, the incidence of restenosis is also increasing, thereby driving the adoption of atherectomy technologies in repeat interventions.

Impact of Industry Transitions on the Coronary Atherectomy Devices Market

As a core segment of the Medical Device industry, the Coronary Atherectomy Devices market develops in line with broader industry shifts. Over recent years, transitions such as Shift from Conventional Angioplasty to Advanced Plaque Modification Techniques and Transition from Generalized Treatment Approaches to Imaging Guided Precision Interventions have redefined priorities across the Medical Device sector, influencing how the Coronary Atherectomy Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Shift from Conventional Angioplasty to Advanced Plaque Modification Techniques

The coronary atherectomy devices industry is transitioning from reliance on conventional balloon angioplasty toward advanced plaque modification techniques. As interventional cardiology increasingly focuses on treating complex and calcified lesions, atherectomy devices are becoming essential for effective lesion preparation. This shift is impacting hospitals and cardiac centers, where clinicians are integrating rotational and orbital systems into routine procedures. For example, complex PCI cases that previously relied solely on balloon dilation now incorporate atherectomy to improve stent outcomes. This transition is driving higher device utilization and encouraging manufacturers to expand advanced product portfolios.
02

Transition from Generalized Treatment Approaches to Imaging Guided Precision Interventions

Another key transition is the move from generalized treatment approaches to imaging-guided precision interventions in cardiovascular care. The growing use of intravascular imaging technologies is enabling cardiologists to better assess plaque composition and tailor atherectomy use accordingly. This shift is influencing both device manufacturers and healthcare providers to adopt more data-driven treatment protocols. For instance, advanced cardiac centers are increasingly combining imaging systems with atherectomy devices to optimize procedural accuracy. This evolution is enhancing clinical outcomes while also increasing demand for integrated solutions, strengthening the role of atherectomy devices in modern interventional cardiology.